While mutation of Flt3-ITD N676 was consistently observed across six independent A-419259-resistant AML cell populations, the possibility exists that changes in the expression of Hck, Fgr, or other target kinases for this inhibitor may also contribute to the resistant phenotype. This evidence concerns the gene FGR and acute myeloid leukemia.